Grant number: U54 HD121579-01

Principal Investigators

• Vernon R. Sutton, MD
• Lindsay C. Burrage, MD, PhD

Lead Institution: Baylor College of Medicine

Diseases Studied

• Propionic acidemia
• Isolated methylmalonic acidemia
• Isovaleric acidemia
• Glutaric aciduria type 1
• Cobalamin C disease
• Other forms of methylmalonic acidemia and homocystinuria

Funding Opportunities

Early Career Fellowship

The overall mission of the ROAR career enhancement core is to recruit and retain a cohort of physicians, physician-researchers, and other researchers with clinical research expertise in rare metabolic disorders, specifically organic acidemias.

Annual funding of $50,000 (total cost, including indirect costs) is available to support a postdoctoral trainee or early career faculty member (within 5 years of residency or fellowship training as of proposed start date of either June 1, 2026 or October 1, 2026) for a one-year period. The ROAR Consortium intends to fund 1-2 awards this cycle with one award starting by June 1, 2026 and another starting by October 1, 2026.

Learn More

Funding Statement

The Rare Organic Acidemias Research Consortium (ROAR) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). ROAR is funded under grant number U54HD121579 as a collaboration between NCATS, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Human Genome Research Institute (NHGRI). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.